Close menu
- Home
- Coronavirus
- Sectors
- Topics
- HSJ Local
- Comment
-
HSJ Knowledge
- Back to parent navigation item
- HSJ Knowledge
- HSJ Partners
- Covid-19 Resources
- Immersive features
- Commissions and inquiries
- Top leader lists
- Roundtables
- Supplement Archive
- HSJ webinars
- HSJ Healthcare Partnership Awards
-
Channels and networks
- Back to parent navigation item
- Channels and networks
- Insight and influence
- Events
- Jobs
- Products & Services
- Subscribe
NICE insiders criticise Alzheimer's drug decision
2006-10-19T00:00:00
The National Institute for Health and Clinical Excellence has been criticised by its own senior advisers for not listening to experts when deciding to limit the use of the only drugs available in the UK for Alzheimer's disease.
You need to be signed in to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All of HSJ.co.uk and our HSJ mobile app
- News and insight on all areas of public funded healthcare
- Expert commentary, insight and analysis from industry leaders
- 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics
HSJ is part of Wilmington Healthcare Limited, Beechwood House, 2-3 Commercial Way, Christy Close, Southfields, Essex, SS15 6EF. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud